Digital Therapeutics (DTx)

We help clients characterize the technology solutions landscape in their therapeutic area, indication, or segment, including identifying the optimal role for digital interventions in the therapy area, assessing the competitive landscape, and evaluating R&D opportunities, potential partnerships, and/or acquisition targets.

Clients rely on us to help determine the unmet needs of patients and providers, the strengths weaknesses of the client’s digital intervention, the drivers and barriers of use, and the best opportunities to monetize the technology, whether it be as a stand-alone therapeutic, an adjunct to another portfolio drug or device, or as a licensing opportunity.

We help clients identify the available pathways to ensure patients can access their digital therapies at a reasonable cost. This includes identifying the relevant market access stakeholders and the evidence required to support coverage and appropriate payment. Additionally, we assist with assessing the perspectives of employers, public payers, and private insurers and developing strategies and tactics to secure favorable reimbursement.